ST
GSK icon

Sabal Trust’s GSK GSK Stock Holding History

Sabal Trust’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-318,223
Closed -$16.6M – 108
2015
Q2 		$16.6M Buy
318,223
+14,388
+5% +$810K 2.16% 28
2015
Q1 		$17.5M Buy
303,835
+56,477
+23% +$3.24M 2.3% 25
2014
Q4 		$13.2M Sell
247,358
-8,024
-3% -$449K 1.71% 34
2014
Q3 		$14.7M Buy
255,382
+6,636
+3% +$407K 1.97% 30
2014
Q2 		$16.6M Buy
+248,746
New +$16.8M 2.37% 26

Other funds holding GSK

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sabal Trust's GSK Position: Q3 2015 in Review

Sabal Trust sold out of GSK (GSK) in Q3 2015, closing a stake of 318,223 shares — an estimated $16.6M sold.

Sabal Trust first reported a position in GSK in Q2 2014 and held it in 5 quarters. The position peaked at $17.5M in Q1 2015. 707 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • Sabal Trust reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
  • Sabal Trust sold 318,223 GSK shares in Q3 2015, an estimated $16.6M.
  • Sabal Trust first reported a position in GSK in Q2 2014 and held it in 5 quarters.
  • Sabal Trust's GSK position peaked at $17.5M in Q1 2015.
  • 707 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Sabal Trust's 13F filing for Q3 2015, filed 22 Oct 2015.